Cargando…
Comprehensive analysis of transcriptome data and experimental identification show that solute carrier 35 member A2 (SLC35A2) is a prognostic marker of colorectal cancer
Background: Colorectal cancer (CRC) is a solid tumor with high morbidity and mortality rates. Accumulating evidence shows that the soluble carrier family 35 member A2 (SLC35A2), a nucleotide sugar transporter, plays a key role in the pathogenesis of various tumors. However, its expression and functi...
Autores principales: | Wang, Yue, Chen, Liang, Chen, Jing, Bai, Zhenzhen, Cao, Liyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637800/ https://www.ncbi.nlm.nih.gov/pubmed/37889544 http://dx.doi.org/10.18632/aging.205145 |
Ejemplares similares
-
Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2023) -
Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer
por: Ta, Hoang Dang Khoa, et al.
Publicado: (2021) -
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
por: Xu, Shengshan, et al.
Publicado: (2023) -
A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2
por: Li, Danyang, et al.
Publicado: (2021) -
SLC35A2-CDG: Novel variant and review
por: Quelhas, Dulce, et al.
Publicado: (2021)